Fig. 11From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisSurvival analysis of MTRNR2L8 in the BC and GC samples, based on the ENCORI a and GEPIA2 b online databasesBack to article page